White Paper

ePROs: Transforming Oncology Trial Research

Source: Medable
GettyImages-1350880819 epro

In the past decade, the number of oncology trials has experienced an astonishing surge, nearly doubling the combined count of trials in all other therapeutic areas, as reported by the WIRB-Copernicus Group¹. Oncology trials, renowned for their intricate designs, frequently pose numerous challenges to participants, research sites, and sponsors, jeopardizing their successful execution. To enhance the design of oncology studies, organizations must confront the issues encountered by participants and research sites.

Sponsors and Contract Research Organizations (CROs) seeking to address these issues and alleviate the burdens on participants and sites should consider the potential of digital solutions, especially electronic informed consent (eConsent) and electronic patient-reported outcomes (ePRO). These tools not only provide comprehensive insights into the participant journey but also furnish valuable feedback, empowering sponsors and CROs to improve and optimize their trials for the benefit of all stakeholders.

Through the adoption of digital solutions, the integration of ePRO measures, the standardization of assessments, and a focus on flexibility and choice, sponsors and CROs can alleviate the challenges faced by participants and research sites. Find out how you can make life easier for patients when it matters most by accessing the white paper below.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader